AV
Atlas Venture Fund X, L.P. Other
US US · SEC (Form 4)
Discover the full record of transactions filed by Atlas Venture Fund X, L.P.. Director active across 3 companies, notably Kymera Therapeutics, Inc.. In total, 16 filings have been published. Total volume traded: €32.4m. The latest transaction was disclosed on 27 September 2021 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations 16 total
€1m 51,294 shares @ €21.9718 31.0% of flow
Common Stock
SEC:0001209191-21-058122 · 27 Sept 2021
€1m 51,294 shares @ €21.9718 15.5% of flow
Common Stock
SEC:0001209191-21-058122:0 · 27 Sept 2021
€676,976 30,560 shares @ €22.1523 18.6% of flow
Common Stock
SEC:0001209191-21-057719 · 22 Sept 2021
€676,976 30,560 shares @ €22.1523 9.3% of flow
Common Stock
SEC:0001209191-21-057719:0 · 22 Sept 2021
01,000,000 shares 0
Common Stock
SEC:0001209191-21-057041:0 · 17 Sept 2021
01,000,000 shares 0
Common Stock
SEC:0001209191-21-057041 · 17 Sept 2021
€13m 242,133 shares @ €51.9507 0.20% mcap 100.0% of flow
Common Stock
SEC:0001209191-21-051015 · 11 Aug 2021
€13m 242,133 shares @ €51.9507 0.20% mcap 100.0% of flow
Common Stock
SEC:0001209191-21-051015:0 · 11 Aug 2021
€580,144 26,858 shares @ €21.6004 16.0% of flow
Common Stock
SEC:0001209191-21-043499 · 24 Jun 2021
€580,144 26,858 shares @ €21.6004 8.0% of flow
Common Stock
SEC:0001209191-21-043499:0 · 24 Jun 2021
€1m 59,978 shares @ €20.8351 34.4% of flow
Common Stock
SEC:0001209191-21-042857 · 21 Jun 2021
€1m 59,978 shares @ €20.8351 17.2% of flow
Common Stock
SEC:0001209191-21-042857:0 · 21 Jun 2021
01,000,000 shares 0
Common Stock
SEC:0001209191-21-042076 · 16 Jun 2021
01,000,000 shares 0
Common Stock
SEC:0001209191-21-042076:0 · 16 Jun 2021
01,122,619 shares 0
Common Stock
SEC:0001209191-21-033694:0 · 18 May 2021
01,122,619 shares 0
Common Stock
SEC:0001209191-21-033694 · 18 May 2021
About Atlas Venture Fund X, L.P. Atlas Venture Fund X, L.P. is a director and insider at Kymera Therapeutics, Inc. and Generation Bio Co.